As of press release, Brain Action Aurora-B has risen 14.23%. The company announced that on the evening of October 27, 2026, it received a Class II medical device registration certificate for cognitive function assessment software for patients with depression issued by the Beijing Drug Administration.

As of press release, Brain Action Aurora-B has risen 14.23%. The company announced that on the evening of October 27, 2026, it received a Class II medical device registration certificate for cognitive function assessment software for patients with depression issued by the Beijing Drug Administration.